Bajaj Healthcare Ltd carries a market capitalization of 11.15B, placing it among publicly traded companies globally. Its enterprise value stands at 15.59B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 11.15B |
| Enterprise Value | 15.59B |
Bajaj Healthcare Ltd trades at a trailing price-to-earnings ratio of 35.27.
| PE Ratio | 35.27 |
| PS Ratio | 2.79 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Bajaj Healthcare Ltd trades at an EV/EBITDA multiple of 28.03 and an EV/FCF ratio of 67.53. The EV/Sales ratio of 2.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.03 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.79 |
| EV / EBITDA | 28.03 |
| EV / EBIT | 28.03 |
| EV / FCF | 67.53 |
Bajaj Healthcare Ltd maintains a current ratio of 3.55, meaning it holds 3.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 94.04, indicating elevated leverage, while an interest coverage ratio of 2.25 demonstrates limited ability to service its debt obligations.
| Current Ratio | 3.55 |
| Quick Ratio | 0.31 |
| Debt / Equity | 94.04 |
| Debt / EBITDA | N/A |
| Interest Coverage | 2.25 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 18.13 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Bajaj Healthcare Ltd has paid 32.73M in income taxes, reflecting an effective tax rate of 6.50.
| Income Tax | 32.73M |
| Effective Tax Rate | 6.50 |
Bajaj Healthcare Ltd's stock has declined approximately -29.67954% over the past 52 weeks. The 50-day moving average sits at 310.57, while the 200-day moving average is 368.47.
| Beta (5Y) | N/A |
| 52-Week Price Change | -29.67954% |
| 50-Day Moving Average | 310.57 |
| 200-Day Moving Average | 368.47 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bajaj Healthcare Ltd generated 5.59B in revenue and converted that into 441.97M in net income, yielding earnings per share of 15.04. EBITDA reached 556.07M, while operating income came in at 556.07M.
| Revenue | 5.59B |
| Gross Profit | 2.58B |
| Operating Income | 556.07M |
| Pretax Income | 503.49M |
| Net Income | 441.97M |
| EBITDA | 556.07M |
| EBIT | 556.07M |
| Earnings Per Share (EPS) | 15.04 |
Bajaj Healthcare Ltd operates with a gross margin of 46.09, reflecting its pricing power and cost economics. The operating margin of 9.94 and net profit margin of 7.90 provide insight into operational efficiency.
| Gross Margin | 46.09 |
| Operating Margin | 9.94 |
| Pretax Margin | 9.00 |
| Profit Margin | 7.90 |
| EBITDA Margin | 9.94 |
Bajaj Healthcare Ltd's most recent stock split took place on September 28, 2021 with a 1:2 split ratio.
| Last Split Date | 9/28/2021 |
| Split Ratio | 1:2 |
Bajaj Healthcare Ltd posts an Altman Z-Score of 7.67, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.67 |